Aditxt, Inc. has entered into an Arrangement Agreement with Adivir, Inc. and Appili Therapeutics, Inc. for the acquisition of all issued and outstanding shares of Appili. The transaction will be completed through a statutory plan of arrangement under the Canada Business Corporation Act, with each Appili Shareholder receiving cash and Aditxt common stock as consideration.